sarcomas

finch canary cage free bird release
Biotech

FDA frees Salarius’ rare cancer asset from clinical hold

The FDA has lifted its partial clinical hold on Salarius’ lead asset in a rare cancer indication.
Gabrielle Masson May 9, 2023 11:20am
Liposarcoma sarcoma

Salarius pauses enrollment of sarcoma trial after patient death

Oct 18, 2022 9:50am
cancer newspaper

Adaptimmune's T-cell therapy clears efficacy bar in solid tumors

Nov 12, 2021 7:05am
Laboratory

ASCO: Adaptimmune’s cell therapy shrinks 39% of rare sarcomas

May 19, 2021 5:00pm
Rain Therapeutics

Rain tees up $100M IPO to push ex-Daiichi cancer drug into phase

Apr 5, 2021 9:45am
This is a photo of the Clinical Research Building of the Perelman School of Medicine at the University of Pennsylvania in Phi

ASH: CRISPR-edited cells prove safe in small cancer study

Nov 7, 2019 10:20am